UB Paderborn / Katalog / Suche / in CDI

Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients

European journal of endocrinology, 2011-09, Vol.165 (3), p.441

2011

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-Iodine Administered Doses for Recombinant Thyrotropin-Stimulated Postoperative Thyroid Remnant Ablation in Differentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2007-09, Vol.92 (9), p.3542-3546

2007

Link zum Volltext

Verfügbarkeit prüfen

Acute exogenous TSH administration stimulates leptin secretion in vivo

European journal of endocrinology, 2010-07, Vol.163 (1), p.63

2010

Link zum Volltext

Verfügbarkeit prüfen

DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients

The journal of clinical endocrinology and metabolism, 2017-05, Vol.102 (5), p.1623-1630

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer

Best Practice & Research Clinical Endocrinology & Metabolism, 2008-12, Vol.22 (6), p.1009-1021

2008

Link zum Volltext

Verfügbarkeit prüfen

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing

International journal of molecular sciences, 2022-04, Vol.23 (9), p.4648

2022

Link zum Volltext

Verfügbarkeit prüfen

Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients

European journal of endocrinology, 2013-07, Vol.169 (1), p.23

2013

Link zum Volltext

Verfügbarkeit prüfen

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5496

2023

Link zum Volltext

Verfügbarkeit prüfen

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer

Cancers, 2023-08, Vol.15 (15), p.4009

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update

Frontiers in endocrinology (Lausanne), 2022-04, Vol.13, p.891903-891903

2022

Link zum Volltext

Verfügbarkeit prüfen

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI

Cancers, 2022-01, Vol.14 (3), p.724

2022

Link zum Volltext

Verfügbarkeit prüfen

Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery

Scientific reports, 2022-06, Vol.12 (1), p.10643-10643, Article 10643

2022

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer

Cancers, 2023-09, Vol.15 (18), p.4656

2023

Link zum Volltext

Verfügbarkeit prüfen

Nodular Thyroid Disease in the Era of Precision Medicine

Frontiers in endocrinology (Lausanne), 2020-01, Vol.10, p.907-907

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis

International journal of molecular sciences, 2017-04, Vol.18 (4), p.775-775

2017

Link zum Volltext

Verfügbarkeit prüfen

Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy

Archives of Endocrinology and Metabolism, 2020-08, Vol.64 (4), p.483-486

2020

Link zum Volltext

Verfügbarkeit prüfen

Lack of Association between Urinary Iodine Excretion and Successful Thyroid Ablation in Thyroid Cancer Patients

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.230-237

2010

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study

Cancers, 2019-10, Vol.11 (10), p.1516

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors

Cancers, 2022-09, Vol.14 (19), p.4569

2022

Link zum Volltext

Verfügbarkeit prüfen

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes

Frontiers in pharmacology, 2020-05, Vol.11, p.684-684

2020

Link zum Volltext

Verfügbarkeit prüfen

Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men

Journal of the American Heart Association, 2022-01, Vol.11 (1), p.e023371-e023371

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.845954-845954

2022

Link zum Volltext

Verfügbarkeit prüfen

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology

Frontiers in endocrinology (Lausanne), 2021-02, Vol.12, p.613727-613727

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

European journal of endocrinology, 2010-08, Vol.163 (2), p.301

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma

European thyroid journal, 2020-07, Vol.9 (4), p.213-220

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients

A Comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-Iodine Administered Doses for Recombinant Thyrotropin-Stimulated Postoperative Thyroid Remnant Ablation in Differentiated Thyroid Cancer

Acute exogenous TSH administration stimulates leptin secretion in vivo

DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing

Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer

Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI

Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer

Nodular Thyroid Disease in the Era of Precision Medicine

Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis

Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy

Lack of Association between Urinary Iodine Excretion and Successful Thyroid Ablation in Thyroid Cancer Patients

Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes

Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma

Suchergebnisse filtern